# Codex Review: medical_monitoring_my008_structural_discovery_20260804

Date: 2026-08-04

## Verdict

**Pass for read-only structural discovery evidence; not an adapter, mapping, medical or release approval.**

## Boundary Check

- Hermes workflow guard task was initialized and its review gate is the final process check; no Hermes
  worker or external provider was dispatched.
- The raw-intake service read only the four explicitly authorized MY008 source files.
- No source registry, adapter, prompt, database/CAS, runtime, project root or user-facing product file changed.

## Codex Verification

- Artifact replay is exact for two projects across all persisted aggregate fields.
- 3-01 and 3-02 retain different sheet counts, domain names, row distributions, unclassified sheets,
  subject/site counts and protocol table/paragraph summaries.
- Provider-disabled and no-cell/no-subject-ID persistence assertions passed.
- Existing raw-intake coverage is included in the full monitoring result: 2024 passed, 25 warnings.
- Reserved ports 8911/5174/8910/4173 remained stopped.

## Findings

The structural profile demonstrates the reusable, project-neutral intake layer can observe materially
different listing shapes without forcing them into one study template. Keeping unclassified sheets
explicit is important: it prevents a premature semantic assumption from looking like a successful
mapping. This is structural evidence only; it does not identify drug treatment roles, endpoints,
clinical rules or risk findings.

## Residual Risk

Field-level mapping, protocol clause extraction, full-source lineage, formal B6 outcomes, source-token/
CAS replay, independent MY008 adapters, runtime identity and browser/scientific acceptance remain open.
8911 must stay stopped until the formal release chain is satisfied.
